Still a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma.
María Jesús Fernández AceñeroJ Martínez-UserosL Díez-ValladaresS García-BotellaL Ortega MedinaE Pérez AguirreS de la Serna EstebanE LatorreL NeelsenPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2018)
Our series show that patients with symptomatic disease at the time of diagnosis and females showed a shorter progression-free and overall survival. We herein propose a regression model to predict outcome.
Keyphrases